Antiphospholipid antibodies: laboratory and pathogenetic aspects.

about

Thrombocytopenias: a clinical point of view.

P2860

Q33384884-C3A22AD7-2FB3-4DCA-A8BB-CC94EEC70FD6

P2860

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

Item

http://www.wikidata.org/entity/Q36799474

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

@en

type

Item

label

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

@en

prefLabel

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

@en

P1476

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

@en

P2093

Samarkos M

http://www.w3.org/2001/XMLSchema#string

Sikara M

http://www.w3.org/2001/XMLSchema#string

Tsiligros P

http://www.w3.org/2001/XMLSchema#string

Vlachoyiannopoulos PG

http://www.w3.org/2001/XMLSchema#string

P2860

The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles

P304

271-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10408360601079549

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17453920

http://www.w3.org/2001/XMLSchema#string

P921

pathogenesis

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

about

P2860

P2860

Antiphospholipid antibodies: laboratory and pathogenetic aspects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921